# Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute

> **NIH NIH R50** · ROSWELL PARK CANCER INSTITUTE CORP · 2020 · $250,131

## Abstract

The current application seeks salary support for Hans Minderman, PhD who serves as the
Assistant Director of the Flow and Image Cytometry Shared Resource (FICSR) of the Roswell
Park Cancer Institute. This position was created in 2007 to oversee the research applications of
the various imaging (confocal, live cell imaging) and flow cytometry platforms available in the
facility, to establish and implement a program for the then novel ImageStream technology and to
apply his extensive experience in these areas in collaborations and consultations with the
FICSR investigator user base. With over 30 years of experience in clinical applications of flow
and image cytometry (25 years at Roswell Park Cancer Institute), Dr Minderman throughout his
career has collaborated with many investigators at the Institute on NIH funded projects. The
tumor immunology & immunotherapy (TII) Cancer Center Support Grant (CCSG) program, co-
led by Dr Odunsi, who serves as the unit director on this application, is the major user base of
the FICSR; and numerous NIH-funded researchers in this program actively collaborate and
consult with Dr Minderman commensurate with the purpose of the PAR16-025 funding
opportunity. Specifically, the ImageStream cytometry applications developed under Dr
Minderman’s direction play an important role in the research efforts of many researchers in the
TII and ovarian SPORE programs led by Dr Odunsi. In the ongoing effort to provide the TII and
SPORE program members with cutting edge cytometry technology, RPCI in December 2015
purchased a Helios cytometer which enables high dimensional multiplex phenotyping of small
sample sizes such as biopsies of the tumor microenvironment. Dr Minderman will apply his
expertise in setting up and implementing the highly successful ImageStream program to
consulting and actively collaborating with Dr Odunsi’s research group to implementing the
Helios technology and developing and validating its applications.

## Key facts

- **NIH application ID:** 9994236
- **Project number:** 5R50CA211108-05
- **Recipient organization:** ROSWELL PARK CANCER INSTITUTE CORP
- **Principal Investigator:** HANS MINDERMAN
- **Activity code:** R50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $250,131
- **Award type:** 5
- **Project period:** 2016-09-20 → 2021-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9994236

## Citation

> US National Institutes of Health, RePORTER application 9994236, Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute (5R50CA211108-05). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/9994236. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*